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Abstract
Mechanical stress plays a key role in the pathogenesis of cartilage destruction seen in os-
teoarthritis (OA). We investigated the effect of cyclic tensile stress (CTS) on the anabolic and
catabolic gene expression of rat cultured normal chondrocytes using the Flexercell strain unit. The
effects of interleukin (IL)-4, a chondroprotective cytokine, on the changes in gene expression in-
duced by CTS were also investigated. CTS (7% elongation at 0.5 Hz) for 24 h did not affect the
expression of aggrecan and type II collagen, whereas CTS significantly upregulated matrix metal-
loproteinase (MMP)-13 and cathepsin B mRNA expression by chondrocytes. IL-1beta expression
was also signifi cantly upregulated by CTS up to 12 h. The upregulation of MMP-13 was observed
at 3 h, which was earlier than that of IL-1beta. Furthermore, pre-treatment with IL-4 (10 ng/ml)
suppressed both MMP-13 and cathepsin B induction by mechanical stress, as well as CTS-induced
IL-1beta expression. Our results suggest that IL-4 might have a therapeutic value in the treatment
of OA by downregulation of mechanical stress-induced MMP-13 and cathepsin B expression by
chondrocytes.
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ggrecan and type II collagen are major extra-
cellular matrix (ECM) components of articular 
cartilage [1].  Aggrecan is highly hydrated because of 
its negatively charged long polysaccharide chains,  thus 
conferring ﬂ exibility to the cartilage to resist mechan-
ical loads,  such as compression,  shearing,  stretching 
stress and hydrostatic pressure.  The degradation or 
loss of aggrecan is considered a critical early event of 
cartilage destruction,  occurring initially at the joint 
surface and then progressing to the deeper zones.  
This is followed by degradation of collagen ﬁ brils and 
mechanical failure of the tissue,  which leads to osteo-
arthritis (OA) [2].
　 It is generally accepted that proteolytic enzymes 
are activated during the disease process [3] and con-
tribute to the loss of ECM in OA [3,  4].  Of these,  
matrix metalloproteinases (MMPs)-1,  3,  8,  13 and 14 
are reportedly responsible for destructive collagenol-
ysis,  and aggrecanases such as cathepsin B and 
ADAMTS (a disintegrin and a metalloproteinase 
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domain with thrombospondin motifs) 1,  4,  5,  8,  9 
and 15 are likely to be responsible for destructive 
aggrecanolysis [5].
　 MMP-13 has a particular role in cartilage degrada-
tion because it is expressed by chondrocytes,  and it 
hydrolyzes type II collagen more eﬃ  ciently than the 
other collagenases [6,  7].  MMP-13 is induced in 
response to the cytokines and growth factors usually 
found in arthritic joints.  In OA,  autocrine secretion 
of inﬂ ammatory cytokines such as IL-1 by chondro-
cytes stimulates MMP-13 expression and cartilage 
degradation in the absence of inﬂ ammatory cells [7,  
8].  Furthermore,  Wong et al. [9] reported that cyclic 
tension upregulated the MMP-13 via upregulation of 
the Cbfa1/MMP-13 pathway.
　 Cathepsin B,  a lysosomal cysteine proteinase,  can 
cleave aggrecan at a site close to that of MMP-3 (also 
known as stromelysin) [10,  11].  Mehraban et al. [12] 
reported that cathepsin B is upregulated in chondro-
cytes and synovial tissue in experimental OA at diﬀ er-
ent time points representing disease progression.  The 
histochemical and pathological distribution of cathep-
sin B in human OA cartilage suggested that it may be 
involved in the perpetuation of OA rather than in the 
initial assault on the cartilage [13,  14].  High levels 
of activity of extracellular cathepsin B has been found 
around clefts and in the zones of hypercellularity in 
OA cartilage [14].  Although the mechanism of upreg-
ulation of cathepsin B expression is still unclear,  IL-1 
reportedly upregulates intracellular cathepsin B by 
increasing its protein synthesis [12].  However,  there 
is little information on the relationship between 
mechanical stress and cathepsin B expression.
　 IL-4 is an anti-inﬂ ammatory cytokine,  like IL-10 
and IL-13,  which is known to suppress pro-inﬂ amma-
tory cytokine production and activities [3].  Previous 
studies have demonstrated the anti-inﬂ ammatory prop-
erties of IL-4 in synovial tissue or in models of arthri-
tis.  In OA synovial tissue,  IL-4 inhibits the produc-
tion of tumor necrosis factor-ｸ and IL-1ｹ [15].  In 
cartilage,  IL-4 acts as an anti-inﬂ ammatory cytokine 
through the downregulation of IL-1-induced MMP-1 
and -3 production [16,  17] and upregulation of tissue 
inhibitor of metalloprotease (TIMP)-1 [17,  18].  
Local overexpression of IL-4 protects cartilage from 
MMP-induced destruction by preventing the activation 
of pro-MMPs during immune complex-mediated arthri-
tis [19].  These results suggest that IL-4 is likely to 
have the potential to antagonize catabolic mediators 
involved in cartilage destruction.  Interestingly,  it has 
been reported that IL-4 also acts as an anti-inﬂ amma-
tory cytokine against mechanical stimulation in an 
autocrine manner via type II receptors in chondro-
cytes [20].
　 In the current study,  we examined the in vitro 
eﬀ ect of IL-4 on mechanical stress-induced MMP-13 
and cathepsin B expression by rat normal chondro-
cytes.  To investigate the mechanism of action of IL-4 
on chondrocyte gene expression,  the expression of 
IL-1ｹ at mRNA and protein levels were also exam-
ined up to 24 h after the application of mechanical 
stress.  The results of the current study suggested 
that IL-4 may exhibit a beneﬁ cial role as a therapeutic 
agent against OA,  at least in part,  by downregulation 
of CTS-induced MMP-13 and cathepsin B expression 
by chondrocytes.
Materials and Methods
　 Chondrocyte culture. Articular cartilage 
obtained from the femoral condyle of 7-day-old Wistar 
rats was aseptically dissected,  and chondrocytes were 
isolated by digestion of cartilage specimens in 0.1ｵ ｸ
-chymotrypsin (Wako,  Osaka,  Japan) and 0.2ｵ col-
lagenase (SIGMA,  Tokyo,  Japan) following the 
method of Bruckner et al. [21].  Chondrocytes were 
seeded in six-well plates (5×104/ml) coated with type 
I collagen (BioFlex collagen 1 culture plate; Flexcell 
International,  McKeesport,  PA,  USA),  cultured in 
3 ml ｸ-minimum essential medium (MEM) containing 
10ｵ fetal bovine serum (FBS),  100 U/ml penicillin 
and 100 mg/ml streptomycin,  and incubated in a 5ｵ 
CO2 humidiﬁ ed incubator at 37 °C for 3 days before 
the start of the experiments.
　 Exposure of chondrocytes to CTS. Cells 
were grown to conﬂ uence on the ﬂ exible surface of the 
BioFlex plates and exposed to cycles of stretch and 
relaxation using a computer-driven,  vacuum-operated,  
stress-providing instrument (Flexercell Strain Unit 
FX-2000; Flexcell International).  The culture plate 
bottoms were deformed in a cyclic manner (1 s on,  1 s 
oﬀ ; 0.5 Hz),  resulting in a 7ｵ elongation of the diam-
eter of the ﬂ exible surface.  Cell morphology with or 
without CTS was examined using a phase-contrast 
microscope.
　 IL-4 treatment. To investigate the eﬀ ect of 
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IL-4 on CTS-induced gene expression,  chondrocytes 
were incubated in ｸ-MEM without FBS with rat 
recombinant IL-4 (rrIL-4) (R&D,  McKinley Place,  
MN,  USA) (0 or 10 ng/ml) under a 5ｵ CO2 atmo-
sphere for 24 h,  and were then loaded with CTS.
　 Real-time polymerase chain reaction (PCR) 
for the quantitative detection of each type of 
mRNA. After the exposure of the cells to the 
CTS for 3,  6,  12,  24 and 36 h total RNA was iso-
lated using ISOGEN (Nippon Gene,  Toyama,  Japan) 
and the concentration and purity were assayed by 
spectrophotometer.  The RNA was reverse-tran-
scripted using ReverTra Ace-ｸ (TOYOBO,  Tokyo,  
Japan).  The sequences of primers for type II collagen,  
aggrecan,  cathepsin B,  MMP-3,  MMP-13 and glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) are 
shown in Table 1.  The primer for IL-1ｹ was pur-
chased from Search-LC (Heidelberg,  Germany).
　 Real-time quantitative PCR reactions were per-
formed on a Lightcycler (Roche Diagnostics,  
Mannheim,  Germany) using a LightCycler-FastStart 
DNA Master SYBR Green I kit (Roche Molecular 
Biochemicals,  Mannheim,  Germany) as recommended 
by the manufacturer.  The ﬁ nal expression value was 
calculated by dividing the expression level of aggrecan,  
MMP-3,  MMP-13,  cathepsin B and IL-1ｹ mRNA by 
the expression level of GAPDH,  and each value at 0 h 
was set as 1.
　 IL-1ｹ enzyme assay. After the exposure of 
the cells to the CTS for 3,  6,  12,  24 and 36 h,  the 
concentration of IL-1ｹ in the supernatant was mea-
sured using a commercially available enzyme-linked 
immunosorbent assay (ELISA) kit (Endogen,  IL,  
USA) and following the manufacturer’s recommenda-
tions.
　 Statistical analysis. The results were exam-
ined by one-way analysis of variance (ANOVA) using 
StatView (SAS Institute Inc.,  version 5).  A value of 
p＜0.05 was considered to indicate a statistically sig-
niﬁ cant diﬀ erence.
Results
　 Eﬀ ect of CTS on type II collagen and aggre-
can mRNA expression in the cultured chondro-
cytes. The chondrocytes had a polygonal morphol-
ogy,  which was not altered by CTS after 24 h (Fig.  
1A and B).  To determine whether or not CTS (7ｵ 
elongation,  0.5 Hz) alters the gene expression of ana-
bolic factors,  we performed real-time quantitative 
PCR for type II collagen and aggrecan.  Fig.  2A 
shows the changes in type II collagen mRNA levels in 
the cell layer when chondrocytes were maintained for 
0 to 36 h with or without CTS.  The level of type II 
collagen mRNA was upregulated slightly during the 
course of incubation up to 36 h.  CTS had a tendency 
to decrease the expression of type II collagen,  but the 
diﬀ erences did not reach signiﬁ cance (Fig.  2A).  
Aggrecan mRNA expression was upregulated fourfold 
at 12 h without CTS and gradually decreased later 
(Fig.  2B).  There was no signiﬁ cant diﬀ erence in 
aggrecan mRNA expression between the cells with and 
without CTS.
　 Eﬀ ect of CTS on MMP-13 and cathepsin B 
mRNA expression in the cultured chondrocytes.
To determine whether or not CTS induces the gene 
expression of the catabolic factors MMP-13 and 
cathepsin B,  we performed real-time quantitative 
PCR at each time point after the application of CTS.  
The level of MMP-13 mRNA was signiﬁ cantly 
increased (10ﾝ25 fold) after 3 h CTS,  and the 
increased expression was continued at 6,  12 and 24 h 
after mechanical stimulation,  and decreased to the 
control level at 36 h (Fig.  3A).  Cathepsin B mRNA 
expression signiﬁ cantly increased (2.5ﾝ3.2 fold) after 
24 h stimulation,  and decreased to the control level 
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Table 1　 Oligonucleotide primer sequences
Upstream Downstream
Type II collagen 5’-CCC AGA ACA TCA CCT ACC AC-3’ 5’-GGT ACT CGA TGA TGG TCT TG-3’
Aggrecan 5’-GAT GTC CCC TGC AAT TAC CA-3’ 5’-TCT GTG CAA GTG ATT CGA GG -3’
MMP-13 5’-GCT TTC CCC GTG TCC TCA AA-3’ 5’-TGA CCT GGG ATT TCC AAA AFA G-3’
Cathepsin B 5’-TTG GGT TCA GCG AGG ACA TA-3’ 5’-TCA GCA GAC ACC TCC ACA TT-3’
GAPDH 5’-AGA ACG GGA AGC TCA CTG G-3’ 5’-TCC ACC ACC CTG TTG CTG TA-3’
3
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after 36 h stimulation (Fig.  3B).
　 Eﬀ ect of IL-4 on CTS-induced MMP-13 and 
cathepsin B. At 24 h,  aggrecan mRNA expression 
was not aﬀ ected by CTS.  IL-4 pre-treatment did not 
inﬂ uence the expression of aggrecan mRNA (Fig.  4A).  
MMP-13 expression was increased by CTS and sig-
niﬁ cantly downregulated by IL-4 pre-treatment (Fig.  
4B).  Cathepsin B mRNA was signiﬁ cantly increased 
by CTS,  and decreased by IL-4 pre-treatment at 24 h 
(Fig.  4C).
　 IL-1ｹ mRNA was upregulated at 24 h after start-
ing stimulation.  IL-4 pretreatment downregulated 
CTS-induced IL-1ｹ expression by 24 h (Fig.  5A).  
The level of the IL-1ｹ protein was also upregulated 
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Fig. 2　 Eﬀ ects of CTS (7% elongation at 0.5 Hz) on type II collagen (A) and aggrecan (B) mRNA expression by rat femoral condyle 
chondrocytes.  The changes in mRNA levels in the chondrocytes of type II collagen and aggrecan were measured by real-time quantitative 
PCR using control GAPDH.  Data were shown as the mean±standard deviation of triplicate determinations.  The experiments were 
repeated 4 times and obtained similar results.
Fig. 1　 A.  Cell appearances under phase contrast microscopy of cultured chondrocytes with (B) or without (A) CTS (7% elongation at 
0.5 Hz) for 24 h.  Bar＝100 µm
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at 24 h after mechanical stimulation.  IL-4 pre-treat-
ment countered its upregulation (Fig.  5B).
Discussion
　 In the investigation of the chondrocyte responses to 
mechanical stimuli,  the results might vary according 
to the type of mechanical stress (compression,  tension 
and shear).  In addition,  the frequency,  duration and 
magnitude of mechanical force all aﬀ ect cellular 
responses,  and are important determinants of the ulti-
mate fate of the articular cartilage.  Agarwal et al.  
[22,  23] reported that mechanical strain of low mag-
nitude results in upregulation of proteoglycan and type 
II collagen synthesis that is drastically inhibited in 
inﬂ amed joints.  By contrast,  mechanical strain of high 
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Fig. 3　 Eﬀ ects of CTS (7% elongation at 0.5 Hz) on MMP-13 (A) and cathepsin B (B) mRNA expression by rat chondrocytes.  The 
changes in the mRNA levels of MMP-13 and cathepsin B in the chondrocytes were measured by real-time quantitative PCR using control 
GAPDH.  Data were shown as the mean±standard deviation of triplicate determinations.  (＊p＜0.05) The experiments were repeated 4 
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magnitude is pro-inﬂ ammatory and initiates cartilage 
destruction while inhibiting matrix synthesis.  In the 
current study,  we applied 7ｵ elongation,  using 
0.5 Hz of CTS on monolayer cultured chondrocytes 
from young animals.  No signiﬁ cant diﬀ erences were 
noted in the expressions of aggrecan and type II col-
lagen mRNA between stimulated and unstimulated 
chondrocytes after CTS,  whereas the expression of 
MMP-13 and cathepsin B was signiﬁ cantly upregu-
lated at 24 h.  MMP-13 and cathepsin B was down-
regulated at normal level at 36 h.  The reason of this 
is unclear.  These results suggested that 7ｵ elonga-
tion,  using 0.5 Hz CTS,  of monolayer chondrocytes 
was not an anabolic stimulus and therefore did not 
increase the expression of anabolic factors,  but rather 
increased that of catabolic factors.
　 The precise mechanism of MMP-13 in response to 
the mechanical stimuli has not been well elucidated.  
Cbfa1 is known to be involved in the expression of its 
target MMP-13,  and Cbfa1 -/- mice show an absence 
of MMP-13 expression.  Previous reports showed that 
CTS,  but not in hydrostatic pressure,  upregulated 
the expression of Cbfa1,  the transcription factor with 
a fundamental role in bone formation,  as well as that 
of MMP-13 in bovine cartilage [9].  Although we 
failed to examine the changes in Cbfa1 expression 
after CTS,  the Cbfa1/MMP-13 pathway might con-
tribute to the early upregulation of MMP-13 mRNA 
expression by rat chondrocytes.
　 Cathepsin B is a lysosomal cysteine proteinase 
which is likely to be involved in the progression of OA 
owing to its activity as an aggrecanase.  The mecha-
nism of cathepsin B expression by chondrocytes has 
not been fully elucidated,  but IL-1 seems to play a 
critical role in cathepsin B induction.  Baici et al. [24] 
reported that the accumulation of cathepsin B in intra-
cellular granules was regularly stimulated by a factor 
of 2ﾝ4 in the presence of IL-1ｹ in rabbit articular 
chondrocytes.  In the current study,  we demonstrated 
the synergic upregulation of IL-1ｹ and cathepsin B 
after CTS between 12 and 24 h,  suggesting the regu-
lation of cathepsin B expression by IL-1ｹ.
　 IL-4 pre-treatment signiﬁ cantly countered the 
mechanical stress-induced upregulation of MMP-13 and 
cathepsin B in the current study.  In the rheumatoid 
synovium,  IL-4 plays an anti-inﬂ ammatory role by 
reducing the production of IL-1ｹ by 2.3 fold and 
increasing that of the IL-1 receptor antagonist 
(IL-1Ra) by 2.8 fold [25].  The synchronized down-
regulation of cathepsin B and IL-1ｹ by IL-4 pre-
treatment might be caused by the inhibitory eﬀ ect of 
IL-4 on CTS-induced IL-1ｹ expression.
　 Deschner et al. reported that high magnitude tensile 
stress generates signals that employ nuclear factor 
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kappa B (NF-κB),  a transcription factor that regu-
lates numerous pro-inﬂ ammatory genes,  including that 
encoding MMP-13 [26].  As MMP-13 was downregu-
lated by IL-4 pre-treatment at 24 h after CTS induc-
tion,  MMP-13 downregulation was also partly associ-
ated with the downregulation of IL-1ｹ,  which 
increases the activity of NF-κB.  However,  MMP-13 
upregulation by CTS was noted at a relatively early 
time point of CTS induction (3 h),  followed by upreg-
ulation of IL-1ｹ.  Because IL-4 might aﬀ ect the IL-1-
independent upregulation of MMP-13,  it would be 
interesting to investigate the eﬀ ect of IL-4 on CTS-
induced activation of transcription factors,  such as 
Cbfa1.
　 The eﬀ ects of IL-1 are inhibited in vitro and in vivo 
by natural inhibitors such as IL-1 receptor antagonist 
by blocking its interaction with cell surface receptors.  
Inhibition of IL-1 has been proven to result in amelio-
ration of osteoarthritis-like pathology in osteoarthritic 
culture model [27].  In the current study,  we failed to 
examine the IL-1ｹ -independent eﬀ ect of IL-4 on 
cathepsin B expression by CTS,  with the blockage of 
IL-1ｹ by exogenous IL-1Ra.  It was reported that 
IL-1ｹ antagonist (a single intraarticular injection of 
50 or 150 mg) had no analgesic eﬀ ect during 3 months 
of follow-up in a ﬁ rst randomized placebo-controlled 
trial [28].  These ﬁ ndings and the results of the cur-
rent study suggest that beneﬁ t of IL-4 on the mechan-
ical stress-induced expressions of catabolic factors 
might be limited to the early degenerative change of 
cartilage,  and in the later stage of OA,  it might be 
diﬃ  cult to suppress all MMPs and other enzymes 
involved in the cartilage destruction even by the total 
suppression of IL-1ｹ by IL-1Ra.
　 In conclusion,  the current study demonstrated that 
MMP-13 and cathepsin B are upregulated by CTS 
(7ｵ elongation,  0.5 Hz for 24 h) in rat normal chon-
drocytes.  Pre-treatment with IL-4 eﬀ ectively inhib-
ited the CTS-induced expression of MMP-13 and 
cathepsin B,  which might have been partly caused by 
the regulation of CTS-induced IL-1ｹ expression by 
IL-4.  Further study would be needed to explore the 
role of IL-4 on the changes in mechanical stress-
induced transcriptional gene regulation in chondro-
cytes.
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